All stock lists
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
3.81+0.11 (+2.84%)
Insider Score
––Not scored
RXRX Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
RXRX Stock Insider Trading Activity
RXRX stock’s insider trading shows 10 sales on the open market for an estimated $1.06M by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Scored window · last 90 days0 qualifying buys0 insiders$0 bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| HERSHBERG ROBERT Director | Sell | 25,000 | $5.00 | $125.00K | 13.4% | 162,156 | Oct 6, 2026 | — | Form 4 |
| Borgeson Blake Director | Sell | 50,000 | $4.84 | $242.00K | 0.8% | 6,108,287 | Oct 6, 2026 | — | Form 4 |
| HERSHBERG ROBERT Director | Option exercise | 25,000 | $2.22 | $55.50K | 15.4% | 187,156 | Oct 6, 2026 | — | Form 4 |
| Dar Zavain Director | Award | 4,607 | — | — | 1.9% | 245,371 | Oct 1, 2026 | — | Form 4 |
| Li Dean Y Director | Award | 3,378 | — | — | 0.2% | 1,476,707 | Oct 1, 2026 | — | Form 4 |
| Taylor Ben R CFO | Tax withheld | 5,396 | $3.41 | $18.40K | 0.5% | 1,071,462 | Sep 15, 2026 | — | Form 4 |
| Khan Najat CEO | Sell | 22,408 | $3.52 | $78.82K | 1.1% | 2,072,890 | Sep 8, 2026 | — | Form 4 |
| Borgeson Blake Director | Sell | 30,000 | $3.34 | $100.20K | 0.5% | 6,158,287 | Sep 1, 2026 | — | Form 4 |
| Hallett David Other | Tax withheld | 26,657 | $3.16 | $84.24K | 2.5% | 1,043,837 | Aug 17, 2026 | — | Form 4 |
| Taylor Ben R CFO | Tax withheld | 25,018 | $3.16 | $79.06K | 2.3% | 1,076,858 | Aug 17, 2026 | — | Form 4 |
| Khan Najat CEO | Tax withheld | 80,498 | $3.16 | $254.37K | 3.7% | 2,095,298 | Aug 17, 2026 | — | Form 4 |
| Borgeson Blake Director | Sell | 30,000 | $3.25 | $97.50K | 0.5% | 6,188,287 | Aug 4, 2026 | — | Form 4 |
| Borgeson Blake Director | Sell | 40,000 | $3.96 | $158.50K | 0.6% | 6,218,287 | Jul 7, 2026 | — | Form 4 |
| Li Dean Y Director | Award | 3,747 | — | — | 0.3% | 1,473,329 | Jul 1, 2026 | — | Form 4 |
| Dar Zavain Director | Award | 5,109 | — | — | 2.2% | 240,764 | Jul 1, 2026 | — | Form 4 |
| Bumpus Namandje Director | Sell | 3,963 | $3.18 | $12.60K | 3.0% | 127,632 | Jun 18, 2026 | — | Form 4 |
| Dar Zavain Director | Award | 88,424 | — | — | 60.1% | 235,655 | Jun 17, 2026 | — | Form 4 |
| Li Dean Y Director | Award | 88,424 | — | — | 6.4% | 1,469,582 | Jun 17, 2026 | — | Form 4 |
| Bumpus Namandje Director | Award | 88,424 | — | — | 205% | 131,595 | Jun 17, 2026 | — | Form 4 |
| Sun Elaine D Director | Award | 88,424 | — | — | 186% | 135,981 | Jun 17, 2026 | — | Form 4 |
| Michor Franziska Director | Award | 88,424 | — | — | 69.6% | 215,477 | Jun 17, 2026 | — | Form 4 |
| HERSHBERG ROBERT Director | Award | 88,424 | — | — | 120% | 162,156 | Jun 17, 2026 | — | Form 4 |
| Borgeson Blake Director | Award | 88,424 | — | — | 1.4% | 6,258,287 | Jun 17, 2026 | — | Form 4 |
| Taylor Ben R CFO | Tax withheld | 5,396 | $3.15 | $17.00K | 0.5% | 1,101,876 | Jun 15, 2026 | — | Form 4 |
| Khan Najat CEO | Sell | 23,588 | $3.58 | $84.45K | 1.1% | 2,175,796 | Jun 5, 2026 | — | Form 4 |
| Gibson Christopher Director | Sell | 40,000 | $3.62 | $144.80K | 4.3% | 883,735 | Jun 5, 2026 | — | Form 4 |
| Gibson Christopher Director | Converted | 40,000 | — | — | 4.5% | 923,735 | Jun 5, 2026 | — | Form 4 |
| Bumpus Namandje Director | Sell | 4,386 | $3.54 | $15.53K | 9.2% | 43,171 | Jun 3, 2026 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Sell (S) — Open-market or private sale
- Award (A) — Grant or award from the company, not a purchase
- Tax withheld (F) — Shares withheld to pay tax or an exercise price
- Option exercise (M) — Exercise or conversion of an exempt derivative
- Converted (C) — Conversion of a derivative security into shares
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.